QSS
BMRN icon

Quantitative Systematic Strategies’s BioMarin Pharmaceuticals BMRN Stock Holding History

Quantitative Systematic Strategies’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8,000
Closed -$604K – 484
2021
Q1 		$604K Sell
8,000
-4,360
-35% -$356K 0.09% 331
2020
Q4 		$1.08M Buy
12,360
+1,108
+10% +$87.8K 0.15% 222
2020
Q3 		$856K Sell
11,252
-1,681
-13% -$170K 0.15% 200
2020
Q2 		$1.59M Buy
12,933
+5,274
+69% +$524K 0.32% 89
2020
Q1 		$647K Sell
7,659
-3,842
-33% -$331K 0.53% 58
2019
Q4 		$972K Sell
11,501
-1,996
-15% -$151K 0.14% 227
2019
Q3 		$910K Buy
+13,497
New +$1.04M 0.21% 145
2016
Q3 		– Sell
-12,716
Closed -$996K – 386
2016
Q2 		$996K Buy
12,716
+9,405
+284% +$800K 0.47% 47
2016
Q1 		$259K Buy
3,311
+459
+16% +$37.3K 0.1% 220
2015
Q4 		$301K Buy
+2,852
New +$298K 0.08% 753
2015
Q3 		– Sell
-3,585
Closed -$480K – 378
2015
Q2 		$480K Sell
3,585
-1,135
-24% -$141K 0.11% 316
2015
Q1 		$610K Buy
4,720
+1,226
+35% +$130K 0.17% 174
2014
Q4 		$319K Sell
3,494
-782
-18% -$65K 0.13% 219
2014
Q3 		$311K Buy
+4,276
New +$281K 0.18% 208

Other funds holding BMRN

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Quantitative Systematic Strategies's BMRN Position: Q2 2021 in Review

Quantitative Systematic Strategies sold out of BioMarin Pharmaceuticals (BMRN) in Q2 2021, closing a stake of 8,000 shares — an estimated $604K sold.

Quantitative Systematic Strategies first reported a position in BMRN in Q3 2014 and held it in 14 quarters. The position peaked at $1.59M in Q2 2020. 529 funds tracked by Wall St. Rank hold BMRN as of Q2 2021.

  • Quantitative Systematic Strategies reported no remaining BioMarin Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 8,000 BioMarin Pharmaceuticals shares in Q2 2021, an estimated $604K.
  • Quantitative Systematic Strategies first reported a position in BioMarin Pharmaceuticals in Q3 2014 and held it in 14 quarters.
  • Quantitative Systematic Strategies's BioMarin Pharmaceuticals position peaked at $1.59M in Q2 2020.
  • 529 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2021.

Based on Quantitative Systematic Strategies's 13F filing for Q2 2021, filed 5 Aug 2021.